glp-1 weight loss manhattan Therapy NYC Understanding GLP-1 Weight Loss: Insights

It is even more significant in Mounjaro (tirzepatide) which will likely be FDA approved by the end of the year for weight loss

(Of course, these drugs can have side effects of their own.) Common ones include: Metformin (which can also cause diarrhea) Empagliflozin ( Jardiance ) Glimepiride (Amaryl) Sitagliptin (Januvia) Each drug works differently to treat diabetes

Sitagliptin, linagliptin, and alogliptin undergo minimal metabolism [66, 71, 72]

While results can vary from person to person, this kind of personalized, physiology-supportive approach can be a helpful option for individuals seeking gentler, non-pharmaceutical support

In a new report, JPMorgans pharmaceutical team estimates GLP-1 drugs such as semaglutides are used in 10 to 12 percent of type 2 diabetes patients in the US, leaving room for expansion for both Novo Nordisk and Eli Lillys tirzepatide, also known as Mounjaro